Strength
105; 45 mg/1; mg/1
Manufacturer
Axsome Therapeutics, Inc.NDC
81968004530
Classification
Brand
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA215430On Market Since
8/18/2022
Pharmacological Classes
Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
Related Drugs
Same classification
THERAFLU EXPRESSMAX COLD-COUGH
Brand
00067812708•Haleon US Holdings LLC
$0.0214
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081212•The Procter & Gamble Manufacturing Company
$0.0235
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081512•The Procter & Gamble Manufacturing Company
$0.0235
per ML
ADT ROBITUSSIN PEAK CLD M-S LQ
Brand
00031874220•Haleon US Holdings LLC
$0.0284
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081208•The Procter & Gamble Manufacturing Company
$0.0293
per ML
VICKS NYQUIL SEVERE COLD-FLU
Brand
37000081508•The Procter & Gamble Manufacturing Company
$0.0293
per ML
VICKS DAYQUIL SEVERE COLD-FLU
Brand
37000081008•The Procter & Gamble Manufacturing Company
$0.0303
per ML
ADT ROBITUSSIN PEAK CLD M-S LQ
Brand
00031874214•Haleon US Holdings LLC
$0.0368
per ML
ROBITUSSIN COUGH-COLD CF LIQ
Brand
00031871612•Haleon US Holdings LLC
$0.0372
per ML
ROBITUSSIN LONG-ACTING LIQ
Brand
00031869312•Haleon US Holdings LLC
$0.0375
per ML